Computational analysis of the active sites in binary and ternary complexes of the vitamin D receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 305-309

  Sicinska, Wanda ^a   Rotkiewicz, Piotr ^b  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Changes of residue orientations upon ligand and peptide binding; Interactions with co modulators; Vitamin D receptor

Indexed keywords

AMINO ACID; CALCITRIOL; LEUCINE; LYSYLASPARAGINYLHISTIDYLPROLYLMETHIONYLLEUCYLMETHIONYL ASPARAGINYLLEUCYLLEUCYLLYSYLASPARTYLASPARAGINE; PEPTIDE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BINDING SITE; BIOCHEMISTRY; BIOLOGICAL ACTIVITY; COMPLEX FORMATION; COMPUTER PROGRAM; CONFORMATIONAL TRANSITION; LIGAND BINDING; PROTEIN ANALYSIS;

BINDING SITES; BIOMIMETIC MATERIALS; COMPUTER SIMULATION; MODELS, MOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITRIOL; SOLVENTS;

EID: 33947127037     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.12.077     Document Type: Article

References (11)

1. Tocchini-Valentini G.D., Rochel N., Wurtz J.M., Mitschler A., and Moras D. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5491-5496
2. Eelen G., Verlinden L., Rochel N., Claessens F., De Clerc P., Vandewalle M., Tochini-Valentini G., Moras D., Bouillon R., and Verstuyf A. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor co-activator interaction. Mol. Pharmacol. 67 (2005) 1566-1573
3. 3 hormone analogues and a LXXLL-containing co-activator peptide. Biochemistry 43 (2004) 4101-4110
4. 3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. J. Med. Chem. 41 (1998) 4662-4674
5. H.F. DeLuca, R.R. Sicinski, S. Gowlugari, L.A. Plum, M. Clagett-Dame, 1α-hydroxy-2-methylene-19-nor-homopreganacalciferol and its uses, US Patent 6,440,953 (2002).
6. Biodesigner, Molecular Modeling and Visualization Program, http://www.pirx.com.
7. Sybyl, Modeling Program, 7.0 ed. Tripos Inc., St. Louis, MO.
8. DSSP, updated CMBI version by ElmK.
9. Yamada S., Shimizu M., and Yamamoto K. Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor. Med. Res. Rev. 23 (2003) 89-115
10. DeepView/Swiss-PdbViewer version 3.7, http://www.expasy.org/spdb.
11. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., McKee D.D., Galardi C.M., Plunket K.D., Nolte R.B., Parks D.J., Moore J.T., Kliewer S.A., Willson T.M., and Stimmmel J.B. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα. Nature 415 (2002) 813-817